Lyka Labs Q3 FY26: standalone profit returns, consolidated dip

Net loss reportedRevenue declinedResults View source PDF Explain this filing

LYKALABS · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close

-2.4%Reaction day

₹73.20

prior close

₹73.75

announcement price

After-mkt

timing

Nifty Microcap 250market · in no size index; the smallest one is used+1.8%-4.2% vs market

Pharmaceuticals peers, median of 157sector+1.0%-3.4% vs sector

On the reaction day the stock moved 4.2 pts less than Nifty Microcap 250 and 3.4 pts less than its Pharmaceuticals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark

Stock

+0.3

10m

+0.3

15m

-0.3

30m

-0.5

Sessions after the filingfrom the prior close

StockMarketvs marketSectorvs sector

Reaction day

-2.4+1.8-4.2+1.0-3.4

Next day

-5.6+0.5-6.1+0.4-6.0

-3.6+4.3-7.9+2.4-6.1

-0.8+5.6-6.5+3.0-3.8

-2.5+4.6-7.1+2.2-4.7

-3.4+3.8-7.2+2.1-5.6

-0.3+7.5-7.8+4.4-4.7

15d

-13.7+3.8-17.5+1.2-14.9

-17.2-0.3-16.8-0.5-16.7

-37.6-9.6-28.0-10.1-27.5

-18.4+9.9-28.4+3.2-21.6

UpDownMarket · Nifty Microcap 250Sector · Pharmaceuticals peers, median of 157Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

Lyka Labs Q3 FY26 ended December 2025. Standalone revenue from operations was about flat at Rs 30.73 crore; PAT swung to about Rs 26 lakh profit from Rs 3.63 crore loss YoY. Nine-month standalone PAT was Rs 6.92 crore vs Rs 2.53 crore loss. Consolidated revenue fell to Rs 30.73 crore from Rs 33.80 crore, and Q3 consolidated PAT turned to about Rs 15 lakh loss from Rs 2.70 crore profit. Auditors gave an unqualified opinion.

Likely market impact

Standalone turnaround is positive, but consolidated revenue drop and return to loss raise concern over subsidiaries.